Advisory boutique · United States
MTS Health Partners
- Deals
- 4
- M&A
- 3
- Equity raisings
- 1
- Latest
- Aug 2026
Deals
Deals dated after 30 September 2026 are still being collected.
Columns
4 of 4 deals
| Advisers | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 2026 | Skye Bioscience | – | – | Placement | Placement agent to the lead managers | Announced | 68.0 | Biotech+1 | Leerink Partners (lead manager)Mintz (lead manager) | Skye Bioscience placement |
| Jun 2026 | Theravance Biopharma | – | Zymeworks | Acquisition | Financial adviser to Zymeworks (acquirer) | Pending | 929.0 | Pharma+1 | Lazard (sell-side)Evercore (sell-side)Skadden, Arps, Slate, Meagher & Flom (sell-side)Arthur Cox (sell-side)Kirkland & Ellis (buy-side)Matheson (buy-side) | Zymeworks acquisition of Theravance Biopharma |
| May 2026 | Cross Country Healthcare | – | Knox Lane | Acquisition | Financial adviser to Knox Lane (acquirer) | Completed | 437.0 | Healthcare Staffing | BofA Securities (sell-side)Davis Polk (sell-side)Kirkland & Ellis (buy-side) | Knox Lane acquisition of Cross Country Healthcare |
| Jan 2026 | Alma | – | Spring Health | Acquisition | Financial adviser to Alma (target) | Announced | – | Healthcare Software+1 | Cooley (buy-side)Gunderson Dettmer (sell-side)J.P. Morgan (buy-side) | Spring Health acquisition of Alma |
Activity
By announcement date; raisings and IPOs by their own date.
Sector of the business bought or funded.
Disclosed value in US dollars.
Most often across the table
- BofA Securities
1 dealCompare - Davis Polk
1 dealCompare - Lazard
1 dealCompare - Evercore
1 dealCompare - Skadden, Arps, Slate, Meagher & Flom
1 dealCompare - Arthur Cox
1 dealCompare - Cooley1 dealCompare
- J.P. Morgan
1 dealCompare
Firms advising the other side of the same deals.